Vimta Labs Limited

Healthcare · Healthcare Services

NSE: VIMTALABS BSE: 524394

₹571.75

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. This company ranks #25 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Apollo Hospitals Enterprise Limited	114,812	73.1	20.1%	4.2%	—	73	0	27
Max Healthcare Institute Limited	89,246	124.3	13.4%	-19.5%	0.22%	77	0	26
Fortis Healthcare Limited	57,664	255.5	10.5%	-27.5%	0.13%	49	26	6
Global Health Limited	35,830	74.4	13.9%	-2.5%	0.04%	74	0	30
Aster DM Quality Care Limited	35,828	205.8	8.8%	2.8%	0.43%	53	0	26
Narayana Hrudayalaya Ltd.	35,199	61.9	17.8%	-3.7%	0.26%	66	0	29
Dr. Lal Path Labs Ltd.	33,046	38.4	20.1%	-38.0%	0.99%	82	0	88
Krishna Institute of Medical Sciences Limited	29,629	105.1	9.5%	-2.3%	—	47	0	29
Vimta Labs Limited (this stock)	2,554	32.0	17.0%	-22.8%	0.35%	79	4	32

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹2,534 Cr

EV / EBITDA

16.4x

EV / Sales

6.05x

Market cap / Sales

6.10x

Earnings yield

3.12%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 113 Cr, up 13.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 21 Cr, up 11.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	109	28	21	₹4.7100
March 31, 2026	109	29	21	₹4.7300
Dec. 31, 2025	99	23	18	₹3.9600
Sept. 30, 2025	102	26	20	₹4.4600
June 30, 2025	98	25	19	₹4.2500
March 31, 2025	94	25	18	₹
Dec. 31, 2024	89	23	21	₹7.6500
Sept. 30, 2024	83	21	15	₹7.3800
June 30, 2024	80	16	12	₹5.2500
March 31, 2024	78	16	12	₹5.3400
Dec. 31, 2023	80	13	9	₹4.2600
Sept. 30, 2023	72	8	6	₹2.6700
June 30, 2023	82	16	12	₹5.2500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	113	112	100	105	99	90	84	81	79	81	74	83	81
Operating revenue	109	109	99	102	98	89	83	80	78	80	72	82	81
Other income	4	3	2	3	2	1	1	1	0	1	2	1	1
Operating expenses	72	70	64	68	64	56	54	57	55	59	57	58	57
Operating profit	37	39	34	34	34	32	29	24	24	21	15	24	24
Operating profit margin	34.2%	36.0%	34.7%	33.6%	34.5%	36.5%	34.8%	29.4%	30.2%	26.1%	21.2%	29.0%	29.2%
Depreciation	13	13	11	10	10	10	8	8	8	9	9	8	8
Interest	0	0	0	0	0	1	0	0	1	1	1	0	0
Exceptional items, gain / (loss)	—	—	-2	—	—	—	—	—	—	—	—	—	—
Profit before tax	28	29	23	26	25	23	21	16	16	13	8	16	16
Tax	7	8	6	6	6	6	5	4	4	3	2	4	4
Net profit	21	21	18	20	19	—	—	12	12	9	6	12	12
EPS	4.71	4.73	3.96	4.46	4.25	7.65	7.38	5.25	5.34	4.26	2.67	5.25	5.54
Net profit (TTM)	80	78	—	—	—	—	—	39	39	39	40	47	47
EPS (TTM)	17.86	17.40	20.32	23.74	24.53	25.62	22.23	17.52	17.52	17.72	17.96	21.20	21.39

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	407	104	78
March 31, 2025	344	89	67
March 31, 2024	313	52	39
March 31, 2023	315	64	47

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	9.3%	14.7%	416^†	—	317^†	319^†	277^†	210^†	184^†	215^†	182^†	154^†
Operating revenue	8.9%	14.3%	407	344	313	315	276^†	209^†	181^†	213^†	181^†	153^†
Other income	—	—	9^†	—	4^†	3^†	1^†	1^†	3^†	2^†	1^†	1^†
Operating expenses	—	—	266^†	—	229^†	222^†	196^†	156^†	151^†	155^†	136^†	—
Operating profit	14.8%	21.8%	142^†	—	84^†	94^†	80^†	53^†	30^†	58^†	45^†	—
Operating profit margin	—	—	34.7%^†	—	26.7%^†	29.7%^†	28.9%^†	25.2%^†	16.6%^†	27.1%^†	25.0%^†	—
Depreciation	—	—	44^†	—	34^†	31^†	23^†	23^†	21^†	20^†	16^†	—
Interest	—	—	1^†	—	2^†	3^†	1^†	2^†	4^†	5^†	5^†	2^†
Exceptional items, gain / (loss)	—	—	-2^†	—	0^†	0^†	-1^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	17.7%	29.6%	104	89	52	64	55^†	28^†	8^†	35^†	26^†	16^†
Tax	—	—	26^†	—	13^†	17^†	14^†	7^†	1^†	10^†	9^†	—
Net profit	17.9%	29.5%	78	67	39	47	41^†	21^†	7^†	25^†	16^†	10^†
EPS	-6.7%	12.6%	17.40^†	—	17.52^†	21.39^†	18.57^†	9.61^†	3.13^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	34.7%^†	—	26.7%^†	29.7%^†	28.9%^†	25.2%^†	16.6%^†	27.1%^†	25.0%^†	—
EBIT margin	25.8%^†	—	17.1%^†	21.1%^†	20.6%^†	14.6%^†	6.7%^†	18.7%^†	17.0%^†	11.6%^†
PBT margin	25.5%	25.9%	16.5%	20.3%	20.1%^†	13.6%^†	4.6%^†	16.5%^†	14.1%^†	10.2%^†
Net margin	19.0%	19.6%	12.4%	15.0%	14.9%^†	10.2%^†	3.8%^†	11.9%^†	9.1%^†	6.5%^†
Interest coverage	90.08x^†	—	25.39x^†	25.14x^†	38.00x^†	14.10x^†	3.22x^†	8.63x^†	5.92x^†	8.52x^†
Dividend payout	11.5%^†	—	11.4%^†	9.4%^†	10.8%^†	0.0%^†	63.9%^†	—	—	—
Earnings retention	88.5%^†	—	88.6%^†	90.6%^†	89.2%^†	100.0%^†	36.1%^†	—	—	—
Current ratio	3.43x	2.92x	—	—	—	—	—	—	—	—
Quick ratio	2.97x	2.53x	—	—	—	—	—	—	—	—
Debt to equity	0.01x	0.02x	—	—	—	—	—	—	—	—
Return on equity	17.0%	17.8%	—	—	—	—	—	—	—	—
Return on assets	13.8%	14.4%	—	—	—	—	—	—	—	—
Return on capital employed	21.2%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.72x	0.74x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	147	-130	-10	100	47
March 31, 2025	95	-76	-17	79	16
March 31, 2024	59	-75	-2	75	-16
March 31, 2023	87	-57	-11	48	39
March 31, 2022	59	-38	-16	30	29

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	562	457	448	2	2	225	66	23	300	30
March 31, 2025	467	379	374	5	3	188	64	16	224	25
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.